It's time to connect a better way — and Otsuka Precision Health is building a future where high-tech, high-touch solutions empower a holistic health experience. Data and technology uncover unmet needs and enhance delivery, making care and education simple and obtainable.

May 6, 2024 · Combining the evidence-based rigor of pharma with a data-first focus on a more individualized approach to supporting patients, OPH has a unique opportunity to bring promising innovations to...

Aug 13, 2024 · OPH’s current focus areas include a variety of technological interventions that help unearth personal health needs and address them as a true collaborator within the broader healthcare ecosystem. OPH is a subsidiary of Otsuka America, Inc. (Otsuka), which is a subsidiary of Otsuka Pharmaceutical Co., Ltd. headquartered in Tokyo, Japan.

May 6, 2024 · Otsuka America, Inc. (OAI) and Click Therapeutics, Inc., signed a collaboration agreement to develop and commercialize prescription digital therapeutics for treatment of MDD, with the intent to address unmet medical needs among …

Aug 13, 2024 · SAN FRANCISO--(BUSINESS WIRE)--Otsuka America, Inc. (OAI) announces Otsuka Precision Health, Inc. (OPH), a company that will serve as a catalyst for delivering the right interventions at the right ...

Oct 7, 2024 · PRINCETON, N.J. & WILMINGTON, Del., October 07, 2024 -- (BUSINESS WIRE)--Otsuka Precision Health, Inc., (OPH), and Amalgam Rx, Inc., (Amalgam) announce the launch of Elevmi™ – an intelligent...

With a team of experienced professionals, OPH focuses on achieving universal health coverage by enhancing primary healthcare systems and services. We leverage cutting-edge technologies to offer localized and integrated solutions, empowering public and …

Otsuka Precision Health personalizes experiences for better total healthcare. Combining the fresh energy of a start-up, backed by the strong foundation of Otsuka, OPH is committed to bringing...

May 9, 2024 · SAN FRANCISO, CA — Otsuka America, Inc. (OAI) announces Otsuka Precision Health, Inc. (OPH), a company that will serve as a catalyst for delivering the right interventions at the right time along patients’ and caregivers’ unique health journeys, ranging from connected health solutions to digital therapeutics, all powered by advanced ...

May 30, 2024 · In announcing the formation of OPH in early May — a subsidiary focused on products ranging from “connected health solutions to digital therapeutics, all powered by advanced analytics tools like artificial intelligence” — Otsuka America Inc. offered the FDA marketing clearance of Rejoyn, a prescription digital therapeutic for major ...